Measures to control an outbreak of pertussis in a neonatal intermediate care nursery after exposure to a healthcare worker

Infection Control and Hospital Epidemiology

Volumn 27, Issue 6, 2006, Pages 541-545

  Bryant, Kristina A ^a   Humbaugh, Kraig ^c   Brothers, Kyle ^a   Wright, Judy ^b   Pascual, F Brian ^d   Moran, John ^d   Murphy, Trudy V ^d  

^a University of Louisville School of Medicine   (United States)

^b Norton Healthcare   (United States)

^c Kentucky Department for Public Health   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANAMNESIS; BORDETELLA PERTUSSIS; CELL CULTURE; CHEMOPROPHYLAXIS; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; DISEASE CONTROL; EPIDEMIC; HEALTH CARE PERSONNEL; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; HUMAN CELL; INFANT; INTENSIVE CARE UNIT; LABORATORY TEST; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; NEWBORN CARE; PERTUSSIS; PHYSICIAN; PNEUMOTHORAX; POLYMERASE CHAIN REACTION; PREMATURITY; PROPHYLAXIS; REVIEW; SEROLOGY; SYMPTOMATOLOGY; VACCINATION;

ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BORDETELLA PERTUSSIS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); DISEASE OUTBREAKS; DISEASE TRANSMISSION, HORIZONTAL; DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; HEALTH PERSONNEL; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFECTION CONTROL; INTENSIVE CARE UNITS, NEONATAL; KENTUCKY; POPULATION SURVEILLANCE; UNITED STATES; WHOOPING COUGH;

EID: 33745798575     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/505666     Document Type: Review

References (30)

1. Kurt TL, Yeager AS, Guenette S, et al. Spread of pertussis by hospital staff. JAMA 1972; 221:264-267.
2. Shefer A, Dales L, Melson M, Wener B, Baron R, Jackson R. Use and safety of acellular pertussis vaccine among adult hospital staff during an outbreak of pertussis. J Infect Dis 1995; 171:1053-1056.
3. McCall BJ, Tilse M, Burt B, Watt P, Barnett M, McCormack JG. Infection control and public health aspects of a case of pertussis infection in a maternity health worker. Commun Dis Intell 2002; 26:584-586.
4. Valenti WM, Pincus PH, Messner MK. Nosocomial pertussis: possible spread by a hospital visitor. Am J Dis Child 1980; 134:520-521.
5. Spearing M, Horvath RL, McCormack JG. Pertussis: adults as a source in healthcare settings. Med J Australia 2002; 177:568-569.
6. Alles S, Watson B, Dash G. Role of healthcare workers in a pertussis outbreak in a neonatal intensive care unit. Paper presented at: Neonatal Vaccination Workshop; 2004; McClean, VA.
7. Centers for Disease Control and Prevention. Guidelines for the control of pertussis in outbreaks. Centers for Disease Control and Prevention: Atlanta, GA, 2000. Available at: http://www.cdc.gov/nip/publications/pertussis/guide.htm. Accessed May 12, 2006.
8. Yih KW, Lett SM, des Eignes FN, Garrison KM, Sipe PL, Marchant CD. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. J Infect Dis 2000; 182:1409-1416.
9. Cooper WO, Griffin MR, Arbogast P, Hickson GB, Gautam S, Ray WA. Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis. Arch Pediatr Adolesc Med 2002; 156:647-650.
10. Mahon BE, Rosenman MB, Kleinman MB. Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis. J Pediatr 2001; 139:380-384.
11. Honein MA, Paulozzi LJ, Himelright IM. Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: a case review and cohort study. Lancet 1999; 354:2101-2105.
12. Mertens PLJM, Stals FS, Schellekens JFP, Houben AW, Huisman J. An epidemic of pertussis among elderly people in a religious institution in the Netherlands. Eur J Clin Micro Infect Dis 1999; 18:242-247.
13. Keital WA, Edwards KM. Pertussis in adolescents and adults: time to reimmunize? Semin Respir Infect 1995; 10:51-57.
14. Dworkin MS. Adults are whooping, but are internists listening? Ann Intern Med 2005; 142:832-835.
15. Couzigou C, Flahault A. Is pertussis being considered as a cause of persistent cough among adults? Eur J Epidemiol 2003; 18:1013-1015.
16. Halperin SA, Botolussi R, Langley JM, et al. A randomized, placebo-controlled trial of erythromycin estolate prophylaxis four household contacts of children with culture-positive Bordetella pertussis infection. Pediatrics 1999; 104:e42.
17. Weber D, Rutala W. Management of healthcare workers exposed to pertussis. Infect Control Hosp Epidemiol 1994; 15:411-415.
18. Statement on management of persons exposed to pertussis and pertussis outbreak control. National Advisory Committee on Immunization, the Advisory Committee on Epidemiology, and the Canadian Pediatric Society. Can Commun Dis Rep 1994; 20:193-200.
19. Guris D, Streble PM, Wharton M. Pertussis: In: Centers for Disease Control and Prevention. Manual for the surveillance of vaccine-preventable diseases. CDC: Atlanta, GA 30333, 1997: Chapter 8.
20. Centers for Disease Control and Prevention. January 2005 Updates-Guidelines for the Control of pertussis outbreaks, 2000. Available at: http://www.cdc.gov/nip/publications/pertussis/guide/htm. Accessed May 12, 2006.
21. US Department of Health and Human Services. Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin-Knoxville, Tennessee, 1999. MMWR Morb Mortal Wkly Rep 1999; 48: 1117-1120.
22. Physicians' Desk Reference. 58th ed. Montvale, NJ: Thompson PDR; 2004.
23. Langley JM, Halperin SA, Boucher FD, Smith B. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC). Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. Pediatrics 2004; 114:e96-101.
24. Bace A, Kuzmanovic N, Zrnic T. Pertussis: simple and short therapy with azithromycin. In: Program and abstracts of the 4th International Conference on Macrolides, Azalides, Streptogramins, and Ketolides, 1998; Barcelona, Spain;. Abstract 6.04.
25. Friedman DS, Curtis R, Schauer SL et al. Surveillance for transmission and antibiotic adverse events among neonates and adults exposed to a healthcare worker with pertussis. Infect Control Hosp Epidemiol 2004; 25:967-973.
26. American Academy of Pediatics. Pertussis. In: Pickering LK, ed. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003.
27. Linnemann CC, Ramundo N, Perlstein PH, Minton SD, Englender GS. Use of pertussis vaccine in a epidemic involving hospital staff. Lancet 1975; 2:540-543.
28. United States Food and Drug Administration. Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed. Available at: http://www.fda.gov/cber/approvltr/tdapave061005L.htm. Accessed May 23, 2006.
29. Calugar A, Orega-Sanchez I, Jahre I, et al. Economic evaluation of a nosocomial pertussis outbreak in Pennsylvania, 2003. In: Program and abstracts of the 42nd Annual Meeting of the Infectious Disease Society of America; September 30-October 3, 2004; Boston, MA. Abstract 196.
30. Wright SW, Decker MD, Edwards KM. Incidence of pertussis in healthcare workers. Infect Control Hosp Epidemiol 1999; 20:120-123.